| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 70.577 | 70.152 | 92.669 | 116.010 | 117.735 | 136.910 | 117.163 | 107.726 | 97.714 | 87.832 |
| Total Income - EUR | 75.977 | 73.723 | 95.168 | 116.498 | 118.704 | 138.185 | 120.308 | 109.944 | 99.570 | 89.570 |
| Total Expenses - EUR | 70.408 | 73.752 | 95.855 | 111.316 | 116.953 | 135.278 | 115.296 | 110.161 | 100.687 | 94.132 |
| Gross Profit/Loss - EUR | 5.569 | -29 | -687 | 5.182 | 1.751 | 2.907 | 5.012 | -217 | -1.117 | -4.562 |
| Net Profit/Loss - EUR | 4.627 | -766 | -1.639 | 4.017 | 563 | 1.625 | 3.947 | -1.151 | -2.063 | -4.821 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Farmacia Belladonna S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 208 | 99 | 670 | 131 | 2.359 | 1.549 | 452 | 359 | 265 | 170 |
| Current Assets | 7.584 | 7.400 | 18.589 | 23.725 | 19.605 | 27.108 | 25.962 | 23.852 | 19.575 | 16.280 |
| Inventories | 7.054 | 6.705 | 11.369 | 11.555 | 11.565 | 13.902 | 12.574 | 13.214 | 13.373 | 10.889 |
| Receivables | 127 | 163 | 5.875 | 11.871 | 7.864 | 12.879 | 13.089 | 9.822 | 5.860 | 4.421 |
| Cash | 402 | 531 | 1.345 | 299 | 176 | 327 | 299 | 815 | 342 | 970 |
| Shareholders Funds | 4.978 | -419 | -2.051 | 2.004 | 2.529 | 4.106 | 7.962 | 5.982 | 2.142 | -2.691 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 2.814 | 7.956 | 21.506 | 22.045 | 19.663 | 24.551 | 18.451 | 18.229 | 17.698 | 19.141 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Belladonna S.r.l.